SFM vs. OLLI: Which Retail Stock Offers Better Upside for Now? — Positive
OLLI SFM Zacks Investment Research — November 27, 2025Ollie's value-driven growth, loyal shopper base and disciplined expansion make it a stronger retail pick than Sprouts Farmers now.
Dollar General (DG) Earnings Expected to Grow: Should You Buy? — Positive
DG Zacks Investment Research — November 27, 2025Dollar General (DG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Donaldson (DCI) Reports Next Week: Wall Street Expects Earnings Growth — Positive
DCI Zacks Investment Research — November 27, 2025Donaldson (DCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? — Neutral
COO Zacks Investment Research — November 27, 2025The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Hormel Foods (HRL) to Report a Decline in Earnings: What to Look Out for — Negative
HRL Zacks Investment Research — November 27, 2025Hormel (HRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hewlett Packard Enterprise (HPE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Neutral
HPE Zacks Investment Research — November 27, 2025Hewlett Packard Enterprise (HPE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ulta Beauty (ULTA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release — Positive
ULTA Zacks Investment Research — November 27, 2025Ulta (ULTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Rubrik, Inc. (RBRK) Report Negative Earnings Next Week? What You Should Know — Negative
RBRK Zacks Investment Research — November 27, 2025Rubrik, Inc. (RBRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nvidia (NASDAQ: NVDA) is under pressure as the chipmaker faces allegations over inflated revenue numbers.
The Charles Schwab Corporation: Rate Cuts Are Not A Problem (Upgrade) — Positive
SCHW Seeking Alpha — November 27, 2025The Charles Schwab Corporation is upgraded to a 'buy' rating, reflecting strong asset gathering and resilience amid Fed rate cuts. SCHW's acquisition of Forge Global strategically expands its private investment offerings, enhancing its competitive edge without materially impacting near-term earnings. Net new assets surged 80% year-over-year, margins remain best-in-class, and net interest margin is poised to surpass 3% by mid-2026.
Disney Focuses on Theme Park Expansion: Will the Plan Deliver? — Positive
DIS Zacks Investment Research — November 27, 2025Disney commits $60B to theme parks over 10 years, projecting growth amid rising costs and competition from Universal's Epic Universe and Six Flags expansion.
RKLB vs. LUNR: Which Space Player Shows Bigger Potential in 2025? — Positive
LUNR RKLB Zacks Investment Research — November 27, 2025Rocket Lab and Intuitive Machines build 2025 momentum as missions, contracts and expanding capabilities draw growing investor attention.
Can Hinge Health Inc. (HNGE) Climb 29.59% to Reach the Level Wall Street Analysts Expect? — Positive
HNGE Zacks Investment Research — November 27, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 29.6% in Hinge Health Inc. (HNGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Think Omnicell (OMCL) Could Surge 30.93%: Read This Before Placing a Bet — Positive
OMCL Zacks Investment Research — November 27, 2025The consensus price target hints at a 30.9% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Does One Stop Systems (OSS) Have the Potential to Rally 42.86% as Wall Street Analysts Expect? — Positive
OSS Zacks Investment Research — November 27, 2025The consensus price target hints at a 42.9% upside potential for One Stop Systems (OSS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Believe Chime Financial, Inc. (CHYM) Could Rally 51.07%: Here's is How to Trade — Positive
CHYM Zacks Investment Research — November 27, 2025The consensus price target hints at a 51.1% upside potential for Chime Financial, Inc. (CHYM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See a 40.17% Upside in IHS Holding (IHS): Can the Stock Really Move This High? — Positive
IHS Zacks Investment Research — November 27, 2025The mean of analysts' price targets for IHS Holding (IHS) points to a 40.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts See a 25.31% Upside in Cousins Properties (CUZ): Can the Stock Really Move This High? — Positive
CUZ Zacks Investment Research — November 27, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 25.3% in Cousins Properties (CUZ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 60.24%: Read This Before Placing a Bet — Positive
ADMA Zacks Investment Research — November 27, 2025The consensus price target hints at a 60.2% upside potential for Adma Biologics (ADMA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Can First Advantage (FA) Climb 26.12% to Reach the Level Wall Street Analysts Expect? — Positive
FA Zacks Investment Research — November 27, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 26.1% in First Advantage (FA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.